Cara Therapeutics Inc. buy Needham & Company LLC
Start price
14.05.24
/
50%
€0.67
Target price
14.05.25
€4.62
Performance (%)
-17.66%
Price
17:27
€0.55
Summary
This prediction is currently active. The prediction for Cara Therapeutics Inc. disappoints with a performance of -17.66%. This prediction currently runs until 14.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cara Therapeutics Inc. | -18.432% |
iShares Core DAX® | -0.683% |
iShares Nasdaq 100 | 0.335% |
iShares Nikkei 225® | -1.486% |
iShares S&P 500 | -0.523% |
Comments by Needham___Company_LL for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for CARA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.68
23.05.24
23.05.24
€4.61
23.05.25
23.05.25
-19.00%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.75
10.04.24
10.04.24
€4.64
10.04.25
10.04.25
-25.33%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.87
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
-36.53%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
05.03.24
05.03.24
€4.61
05.03.25
05.03.25
-29.12%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.56
18.12.23
18.12.23
€5.50
18.12.24
18.12.24
-2.05%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.60
08.08.23
08.08.23
€20.10
08.08.24
08.08.24
-78.55%
17:27
17:27
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.32
04.04.23
04.04.23
€20.09
04.04.24
04.04.24
-81.49%
05.04.24
05.04.24